The MM+M Podcast

Just prior to the long Memorial Day weekend, the FDA gave the nod to Novartis gene therapy Zolgensma for one of the leading genetic causes of infant death — spinal muscular atrophy (SMA). The approval...

29 Touko 201930min

Has Seqster discovered the holy grail of interoperability? The San Diego-based startup has developed a tool that pulls health data from multiple EHRs, connecting the fragmented pipes of healthcare. In...

22 Touko 201938min

Sharon Callahan, CEO of TBWA\WorldHealth and chief client officer of the Omnicom Health Group, joined MM&M senior editor Larry Dobrow to discuss the state of the network-agency union and industry dive...

15 Touko 201934min

Recorded live from the MM&M Transforming Healthcare conference at the Edison Ballroom in midtown Manhattan, this episode of the podcast features Megan Coder, executive director of the Digital Therapeu...

9 Touko 201923min

Long-time agency boss Andrew Schirmer, who’s about a year into his latest role as CEO of Ogilvy Health, stopped by to talk with Larry and Marc about the WPP shop’s integration with Ogilvy and where he...

1 Touko 201938min

We're calling today's episode of The MM&M Podcast "Not Your Father's Dudnyk" during which Marc Iskowitz and Larry Dobrow interview Tom Dudnyk about why he started his own agency and discuss the Transf...

23 Huhti 201935min

Marc Iskowitz and Larry Dobrow speak with Karen Newmark, executive director of the Point of Care Communications Council (POC3), about how she’s working to restore advertiser confidence in the POC chan...

17 Huhti 201930min

MM&M’s Alison Kanski and Marc Iskowitz speak with Nancy Beesley, president and founding partner of HCB Health, about what Tuesday’s spin-off of eye-care client Alcon from Novartis means for her agency...

10 Huhti 201930min